US Patent Issued to Seattle Children's Hospital on June 23 for "Self-inactivating transposase plasmids and uses thereof" (Washington Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,685, issued on June 23, was assigned to Seattle Children's Hospital (Seattle).

"Self-inactivating transposase plasmids and uses thereof" was invented by Michael C. Jensen (Seattle), Joshua Gustafson (Seattle), Joseph Cheng (Seattle), Rachel Wilson (Seattle), Kamila Sabina Gwiazda (Seattle) and Jeremy Bjelajac (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "Some embodiments provided herein relate to gene delivery systems and methods using a single plasmid that carries a self-inactivating transposase gene and a corresponding transposon. Some embodiments include nucleic acids having certain sequences, vector including such nucleic acids, and co...